Overview

C07-001: Safety and Efficacy Study of Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Patients

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
Assess the safety and efficacy of Eculizumab in hemolytic PNH patients.
Phase:
Phase 2
Details
Lead Sponsor:
Alexion Pharmaceuticals
Collaborator:
CMIC Co, Ltd. Japan